Zevia PBC (NYSE:ZVIA – Get Free Report) is projected to release its Q4 2025 results after the market closes on Wednesday, February 25th. Analysts expect Zevia PBC to post earnings of ($0.03) per share and revenue of $39.9560 million for the quarter. Individuals can find conference call details on the company’s upcoming Q4 2025 earning report page for the latest details on the call scheduled for Wednesday, February 25, 2026 at 4:30 PM ET.
Zevia PBC Stock Down 5.7%
ZVIA stock opened at $1.57 on Tuesday. Zevia PBC has a 52-week low of $1.53 and a 52-week high of $3.66. The firm has a market cap of $117.38 million, a P/E ratio of -7.11 and a beta of 0.86. The company’s 50-day simple moving average is $1.96 and its 200-day simple moving average is $2.36.
Insider Activity at Zevia PBC
In related news, major shareholder De Depot Et Placement D. Caisse sold 3,500,000 shares of the business’s stock in a transaction that occurred on Tuesday, January 27th. The stock was sold at an average price of $2.00, for a total transaction of $7,000,000.00. Following the completion of the sale, the insider directly owned 13,550,428 shares in the company, valued at approximately $27,100,856. The trade was a 20.53% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 11.11% of the company’s stock.
Hedge Funds Weigh In On Zevia PBC
Analyst Upgrades and Downgrades
ZVIA has been the topic of a number of recent analyst reports. Craig Hallum assumed coverage on Zevia PBC in a research report on Thursday, January 15th. They set a “buy” rating and a $4.00 price target on the stock. Telsey Advisory Group reiterated an “outperform” rating and set a $6.00 target price on shares of Zevia PBC in a research report on Wednesday, January 14th. Weiss Ratings reissued a “sell (d-)” rating on shares of Zevia PBC in a research note on Wednesday, January 21st. Finally, Zacks Research cut shares of Zevia PBC from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, November 5th. Three research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Zevia PBC presently has an average rating of “Hold” and an average target price of $4.68.
Read Our Latest Stock Report on ZVIA
Zevia PBC Company Profile
Zevia PBC, headquartered in Los Angeles, is a Public Benefit Corporation that produces zero-calorie, naturally sweetened beverages. Founded in 2007, the company went public through a merger with a special purpose acquisition company in March 2021. Zevia’s mission centers on offering healthier drink alternatives by using stevia leaf extract and other plant-based ingredients rather than sugar or artificial sweeteners.
The company’s product portfolio spans multiple categories, including carbonated sodas, sparkling water, energy drinks, mixers and flavored teas.
Featured Articles
- Five stocks we like better than Zevia PBC
- Elon Musk already made me a “wealthy man”
- Elon’s Secret AI Partner?
- Elon Musk: This Could Turn $100 into $100,000
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- REVEALED: Something Big Happening Behind White House Doors
Receive News & Ratings for Zevia PBC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zevia PBC and related companies with MarketBeat.com's FREE daily email newsletter.
